Clinical Trials Directory

Trials / Completed

CompletedNCT00449917

"Visiobiane Anti-age" Effects on Vision Parameters

Study of the Effects of "Visiobiane Anti-age" Dietary Supplement on Macular Pigment Optical Density, Contrast Sensibility and Visual Acuity

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (planned)
Sponsor
PiLeJe · Industry
Sex
Male
Age
45 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the benefits of "Visiobiane Anti-age" dietary supplement on macular pigment optical density, contrast sensibility and visual acuity. Additionally, the study would like to evaluate seric variations of carotenoids and the total antioxydant capacity.

Detailed description

Visiobiane study is a randomized trial of 30 participants designed to assess the effects of oral supplementation of macular xanthophylls (lutein and zeaxanthin) and omega-3 LCPUFAs for the eyes protection. The study will enroll healthy participants aged 45 to 55 years. 15 subjects will be assigned in placebo group and 15 in experimetal group (Visiobiane anti-age). They will be supplemented for 24 weeks

Conditions

Interventions

TypeNameDescription
DRUGlutein
DRUGDHA
DRUGvitamins

Timeline

Start date
2006-09-01
Primary completion
2007-07-01
Completion
2007-11-01
First posted
2007-03-21
Last updated
2011-10-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00449917. Inclusion in this directory is not an endorsement.